The release of histamine and formation of a slow-reacting substance (SRS-A) during anaphylactic shock, The Journal of Physiology, vol.151, issue.3, pp.416-451, 1960. ,
DOI : 10.1113/jphysiol.1960.sp006449
Liberation of histamine and formation of lysocithin-like substances by cobra venom, The Journal of Physiology, vol.94, issue.2, pp.187-226, 1938. ,
DOI : 10.1113/jphysiol.1938.sp003674
The phospholipase A2 superfamily and its group numbering system, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, vol.1761, issue.11, pp.1246-59, 2006. ,
DOI : 10.1016/j.bbalip.2006.07.011
Leukotrienes, New England Journal of Medicine, vol.357, issue.18, pp.1841-54, 2007. ,
DOI : 10.1056/NEJMra071371
Leukotriene Receptors: Crucial Components in Vascular Inflammation, The Scientific World JOURNAL, vol.7, pp.1422-1461, 2007. ,
DOI : 10.1100/tsw.2007.187
Fenofibrate reduces lipoprotein associated phospholipase A2 mass and oxidative lipids in hypertriglyceridemic subjects with the metabolic syndrome, American Heart Journal, vol.155, issue.3, pp.499-508, 2008. ,
DOI : 10.1016/j.ahj.2007.12.012
International Union of Pharmacology XXXVII. Nomenclature for Leukotriene and Lipoxin Receptors, Pharmacological Reviews, vol.55, issue.1, pp.195-227, 2003. ,
DOI : 10.1124/pr.55.1.8
Functional characteristics of cysteinyl-leukotriene receptor subtypes, Life Sciences, vol.71, issue.6, pp.611-633, 2002. ,
DOI : 10.1016/S0024-3205(02)01733-2
The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor, The EMBO Journal, vol.19, issue.19, pp.4615-4642, 2006. ,
DOI : 10.1038/sj.emboj.7601341
Inflammation, Atherosclerosis, and Coronary Artery Disease, New England Journal of Medicine, vol.352, issue.16, pp.1685-95, 2005. ,
DOI : 10.1056/NEJMra043430
The potential link between atherosclerosis and the 5-lipoxygenase pathway: investigational agents with new implications for the cardiovascular field, Expert Opinion on Investigational Drugs, vol.16, issue.12, pp.1879-93, 2007. ,
DOI : 10.1097/FPC.0b013e3280120043
Treatment of asthma with antileukotrienes: First line or last resort therapy?, European Journal of Pharmacology, vol.533, issue.1-3, pp.40-56, 2006. ,
DOI : 10.1016/j.ejphar.2005.12.070
The Effect of Montelukast and Low-Dose Theophylline on Cardiovascular Disease Risk Factors in Asthmatics, Chest, vol.132, issue.3, pp.868-74, 2007. ,
DOI : 10.1378/chest.07-0831
Atherosclerosis, COPD and chronic inflammation, Respiratory Medicine: COPD Update, vol.4, issue.2, pp.60-65, 2008. ,
DOI : 10.1016/j.rmedu.2008.01.007
A Randomized, Placebo-Controlled Trial of a Leukotriene Synthesis Inhibitor in Patients With COPD, Chest, vol.122, issue.1, pp.289-94, 2002. ,
DOI : 10.1378/chest.122.1.289
Effects of a 5-Lipoxygenase???Activating Protein Inhibitor on Biomarkers Associated With Risk of Myocardial Infarction, JAMA, vol.293, issue.18, pp.2245-56, 2005. ,
DOI : 10.1001/jama.293.18.2245
Early Carotid Atherosclerosis in Subjects With Periodontal Diseases, Stroke, vol.36, issue.6, pp.1195-200, 2005. ,
DOI : 10.1161/01.STR.0000165916.90593.cb
Periodontal Disease as a Risk Factor for Ischemic Stroke, Stroke, vol.35, issue.2, pp.496-501, 2004. ,
DOI : 10.1161/01.STR.0000110789.20526.9D
Chronic periodontitis, a significant relationship with acute myocardial infarction, European Heart Journal, vol.24, issue.23, pp.2108-2123, 2003. ,
DOI : 10.1016/j.ehj.2003.10.007
Increased leukotriene concentrations in gingival crevicular fluid from subjects with periodontal disease and atherosclerosis, Atherosclerosis, vol.193, issue.2, pp.389-94, 2007. ,
DOI : 10.1016/j.atherosclerosis.2006.07.003
The oral cavity and age: a site of chronic inflammation? PLoS One, p.1351, 2007. ,
Saliva is one likely source of leukotriene B4 in exhaled breath condensate, European Respiratory Journal, vol.28, issue.6, pp.1229-1264, 2006. ,
DOI : 10.1183/09031936.00151905
Assessment of in vivo 5-lipoxygenase activity by analysis of leukotriene B4 in saliva: Effects of treatment with zileuton, Journal of Allergy and Clinical Immunology, vol.119, issue.5, pp.1267-1275, 2007. ,
DOI : 10.1016/j.jaci.2006.12.650
Leukotriene B4: early mediator of atherosclerosis in obstructive sleep apnoea?, European Respiratory Journal, vol.32, issue.1, pp.113-133, 2008. ,
DOI : 10.1183/09031936.00137107
Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis, Journal of Vascular Surgery, vol.39, issue.6, pp.29-37, 2004. ,
DOI : 10.1016/j.jvs.2004.03.014
URL : http://doi.org/10.1016/j.jvs.2004.03.014
Association Between A Leukotriene C4 Synthase Gene Promoter Polymorphism and Coronary Artery Calcium in Young Women: The Muscatine Study, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.27, issue.2, pp.394-403, 2007. ,
DOI : 10.1161/01.ATV.0000252680.72734.10
The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke, Nature Genetics, vol.36, issue.3, pp.233-242, 2004. ,
DOI : 10.1038/ng1311
Promotor Polymorphisms in Leukotriene C4 Synthase and Risk of Ischemic Cerebrovascular Disease, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.28, issue.5, pp.990-996, 2008. ,
DOI : 10.1161/ATVBAHA.107.158873
Inflammatory signaling through leukotriene receptors in atherosclerosis, Current Atherosclerosis Reports, vol.132, issue.Suppl12, pp.244-51, 2008. ,
DOI : 10.1007/s11883-008-0038-7
Enzymatic modification of low density lipoprotein by purified lipoxygenase plus phospholipase A2 mimics cell-mediated oxidative modification, J Lipid Res, vol.29, pp.745-53, 1988. ,
A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein., Proceedings of the National Academy of Sciences, vol.86, issue.3, pp.1046-50, 1989. ,
DOI : 10.1073/pnas.86.3.1046
Lipoxygenase contributes to the oxidation of lipids in human atherosclerotic plaques., Journal of Clinical Investigation, vol.96, issue.1, pp.504-514, 1995. ,
DOI : 10.1172/JCI118062
Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis, Proceedings of the National Academy of Sciences, vol.100, issue.3, pp.1238-1281, 2003. ,
DOI : 10.1073/pnas.242716099
5-Lipoxygenase is not essential in macrophage-mediated oxidation of low-density lipoprotein, Biochemical Journal, vol.278, issue.1, pp.163-172, 1991. ,
DOI : 10.1042/bj2780163
Assessment of 5-lipoxygenase involvement in human monocyte-mediated LDL oxidation, J Lipid Res, vol.34, pp.69-79, 1993. ,
Leukotriene B4 Receptor Antagonism Reduces Monocytic Foam Cells in Mice, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.22, issue.3, pp.443-452, 2002. ,
DOI : 10.1161/hq0302.105593
Role of Leukotriene B4 Receptors in the Development of Atherosclerosis: Potential Mechanisms, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.24, issue.2, pp.369-75, 2004. ,
DOI : 10.1161/01.ATV.0000110503.16605.15
Inhibition of Atherogenesis in BLT1-Deficient Mice Reveals a Role for LTB4 and BLT1 in Smooth Muscle Cell Recruitment, Circulation, vol.112, issue.4, pp.578-86, 2005. ,
DOI : 10.1161/CIRCULATIONAHA.105.545616
Role of cysteinyl leukotrienes in the proliferation and the migration of murine vascular smooth muscle cells in vivo and in vitro, Cardiovascular Research, vol.76, issue.1, pp.160-166, 2007. ,
DOI : 10.1016/j.cardiores.2007.05.018
Leukotriene B4 signaling through NF-??B-dependent BLT1 receptors on vascular smooth muscle cells in atherosclerosis and intimal hyperplasia, Proceedings of the National Academy of Sciences, vol.102, issue.48, pp.17501-17507, 2005. ,
DOI : 10.1073/pnas.0505845102
Levels of cysteinyl leukotriene receptor mRNA in human peripheral leucocytes: significantly higher expression of cysteinyl leukotriene receptor 2 mRNA in eosinophils, Clinical <html_ent glyph="@amp;" ascii="&"/> Experimental Allergy, vol.165, issue.11, pp.1714-1737, 2001. ,
DOI : 10.1046/j.1365-2222.1999.00710.x
Differential Leukotriene Receptor Expression and Calcium Responses in Endothelial Cells and Macrophages Indicate 5-Lipoxygenase-Dependent Circuits of Inflammation and Atherogenesis, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.23, issue.8, pp.32-38, 2003. ,
DOI : 10.1161/01.ATV.0000082690.23131.CB
Selectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi- LXA(4) and regulation of vascular and inflammatory responses ,
Leukotriene receptors on human pulmonary vascular endothelium, British Journal of Pharmacology, vol.30, issue.8 ,
DOI : 10.1111/j.1476-5381.1995.tb16627.x
Antagonist resistant contractions of the porcine pulmonary artery by cysteinyl-leukotrienes, European Journal of Pharmacology, vol.401, issue.3, pp.381-389, 2000. ,
DOI : 10.1016/S0014-2999(00)00452-0
Directed Vascular Expression of Human Cysteinyl Leukotriene 2 Receptor Modulates Endothelial Permeability and Systemic Blood Pressure, Circulation, vol.110, issue.21, pp.3360-3366, 2004. ,
DOI : 10.1161/01.CIR.0000147775.50954.AA
Effect of 5-lipoxygenase blockade on blood pressure and acetylcholine-evoked endothelium-dependent contraction in aorta from spontaneously hypertensive rats, Journal of Hypertension, vol.24, issue.1, pp.85-93, 2006. ,
DOI : 10.1097/01.hjh.0000198027.76729.b8
Inhibition of leukotriene synthesis with MK-886 prevents a rise in blood pressure and reduces noradrenaline-evoked contraction in L-NAME-treated rats, British Journal of Pharmacology, vol.8, issue.1, pp.186-94, 2003. ,
DOI : 10.1038/sj.bjp.0705405
Leukotriene B4 is an indirectly acting vasoconstrictor in guinea pig aorta via an inducible type of BLT receptor, AJP: Heart and Circulatory Physiology, vol.287, issue.1, pp.419-443, 2004. ,
DOI : 10.1152/ajpheart.00699.2003
Endothelium-dependent vascular responses induced by leukotriene B4, Prostaglandins & Other Lipid Mediators, vol.83, issue.3, pp.209-221, 2007. ,
DOI : 10.1016/j.prostaglandins.2007.01.008
Cysteinyl leukotrienes induce P-selectin expression in human endothelial cells via a non- CysLT1 receptor-mediated mechanism, J Pharmacol Exp Ther, vol.281, pp.655-62, 1997. ,
The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm, Nature Medicine, vol.36, issue.9, pp.966-73, 2004. ,
DOI : 10.1084/jem.20031175
Cysteinyl leukotriene 2 receptor and protease-activated receptor 1 activate strongly correlated early genes in human endothelial cells, Proceedings of the National Academy of Sciences, vol.103, issue.16, pp.6326-6357, 2006. ,
DOI : 10.1073/pnas.0601223103
5-Lipoxygenase-Activating Protein: A Potential Link Between Innate and Adaptive Immunity in Atherosclerosis and Adipose Tissue Inflammation, Circulation Research, vol.100, issue.7, pp.946-955, 2007. ,
DOI : 10.1161/01.RES.0000264498.60702.0d
Association Between 5-Lipoxygenase Expression and Plaque Instability in Humans, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.25, issue.8, pp.1665-70, 2005. ,
DOI : 10.1161/01.ATV.0000172632.96987.2d
Dual Role of Matrix Metalloproteinases (Matrixins) in Intimal Thickening and Atherosclerotic Plaque Rupture, Physiological Reviews, vol.85, issue.1, pp.1-31, 2005. ,
DOI : 10.1152/physrev.00048.2003
Expanding expression of the 5-lipoxygenase/leukotriene B4 pathway in atherosclerotic lesions of diabetic patients promotes plaque instability, Biochemical and Biophysical Research Communications, vol.363, issue.1, pp.30-36, 2007. ,
DOI : 10.1016/j.bbrc.2007.08.134
Increased urinary leukotriene excretion in patients with cardiac ischemia. In vivo evidence for 5-lipoxygenase activation, Circulation, vol.85, issue.1, pp.230-236, 1992. ,
DOI : 10.1161/01.CIR.85.1.230
Leukotrienes D4 and E4 produced in myocardium impair coronary flow and ventricular function after two hours of global ischaemia in rat heart, Cardiovascular Research, vol.27, issue.5, pp.770-773, 1993. ,
DOI : 10.1093/cvr/27.5.770
Myocardial protection by the leukotriene synthesis inhibitor BAY X1005: importance of transcellular biosynthesis of cysteinylleukotrienes, J Pharmacol Exp Ther, vol.276, pp.335-376, 1996. ,
Role of eicosanoid inhibition of ischemia reperfusion injury: intact and isolated rat heart studies, Methods Find Exp Clin Pharmacol, vol.19, pp.223-232, 1997. ,
Oxygen free radical producing leukocytes cause functional depression of isolated rat hearts: Role of leukotrienes, Journal of Molecular and Cellular Cardiology, vol.22, issue.5, pp.555-63, 1990. ,
DOI : 10.1016/0022-2828(90)90957-4
Peptide leukotriene receptor antagonism in myocardial ischaemia and reperfusion, Cardiovascular Research, vol.26, issue.12, pp.1206-1217, 1992. ,
DOI : 10.1093/cvr/26.12.1206
Selective antagonism of peptidoleukotriene response does not reduce myocardial damage opr neutrophil accumulation following coronary artery occlusion with reperfusion, Prostaglandins, vol.37, issue.5, pp.597-613, 1989. ,
DOI : 10.1016/0090-6980(89)90075-0
Myocardial Salvage Induced by REV-5901, Journal of Cardiovascular Pharmacology, vol.10, issue.4, pp.398-406, 1987. ,
DOI : 10.1097/00005344-198710000-00004
Antagonism of leukotriene B4 receptors does not limit canine myocardial infarct size, J Pharmacol Exp Ther, vol.253, pp.58-66, 1990. ,
Role of 5-lipoxygenase in myocardial ischemia-reperfusion injury in mice, European Journal of Pharmacology, vol.571, issue.1, pp.51-55, 2007. ,
DOI : 10.1016/j.ejphar.2007.05.040
Endothelial Cysteinyl Leukotriene 2 Receptor Expression Mediates Myocardial Ischemia-Reperfusion Injury, The American Journal of Pathology, vol.172, issue.3, pp.592-602, 2008. ,
DOI : 10.2353/ajpath.2008.070834
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2258273
Ischemia-reperfusion induced microvascular responses in LDL-receptor ?/? mice, Am J Physiol, vol.276, pp.1647-54, 1999. ,
Low-Density Lipoprotein Receptor Knockout Mice Exhibit Exaggerated Microvascular Responses to Inflammatory Stimuli, Circulation Research, vol.81, issue.2, pp.274-81, 1997. ,
DOI : 10.1161/01.RES.81.2.274
Synthesis of compounds with properties of leukotrienes C4 and D4 in gerbil brains after ischemia and reperfusion, Science, vol.224, issue.4651, pp.886-895, 1984. ,
DOI : 10.1126/science.6719118
Arachidonic acid and leukotriene C4: role in transient cerebral ischemia of gerbils, Neurochemical Research, vol.24, issue.10, pp.1225-1257, 1999. ,
DOI : 10.1023/A:1020916905312
Neuroprotective effect of ONO-1078, a leukotriene receptor antagonist, on transient global cerebral ischemia in rats, Acta Pharmacol Sin, vol.24, pp.1241-1248, 2003. ,
Increased expression of cysteinyl leukotriene receptor-1 in the brain mediates neuronal damage and astrogliosis after focal cerebral ischemia in rats, Neuroscience, vol.140, issue.3, pp.969-79, 2006. ,
DOI : 10.1016/j.neuroscience.2006.02.051